September 30, 2024
VISERA S VIDEO SYSTEM CENTER OLYMPUS OTV-S500
Olympus Corporation (Olympus) will sequentially release a new outpatient imaging platform, VISERA S, integrating the stroboscopy*1 observation function and the NBI*2 observation function, in some regions of European index and asia-oceania from September 2024. For other regions, it will be introduced as preparations for compliance with local regulations are completed.
VISERA S is an endoscopy system for outpatient patients that provides clear images using Olympus' advanced optical technology. By supporting early detection of diseases such as cancer and visualizing important tissue changes, it contributes to high-quality diagnosis. With the release of this product, Olympus aims to improve patient outcomes by enhancing the standards of care pathways such as early detection, diagnosis, stage classification, treatment, and prognosis.
*1An examination in the otolaryngology field that uses a strobe to observe vocal cord vibration.
※2 NBI = Narrow Band Imaging. It is a method of observation that makes it easier to observe fine blood vessels and their patterns on mucous surfaces, emphasizing tissues by irradiating two narrow-band lights that are easily absorbed by hemoglobin in the blood.
*3This product mainly caters to otolaryngology, urology, and obstetrics and gynecology.
※In Japan, the products are not for sale, grant, or loan at the time of release due to being unapproved pharmaceutical and medical devices under the Pharmaceutical and Medical Devices Act.
Overview of the release
| Product name | Release date |
| VISERA S VIDEO SYSTEM CENTER OLYMPUS OTV-S500 | September 2024 (part of the European and Asian/Oceanian regions) |
Key Features
1. Contributes to reliable diagnosis through achieving high-quality images.
2. Integrated video system and stroboscopic light source to improve operability and diagnostic accuracy.
With support for HD camera heads, it enables precise inspections.
By improving the inspection record storage function, it supports efficient follow-up of patients.
Details of the main features
1. Contribute to reliable diagnosis by achieving high image quality.
"VISERA S" has improved color reproducibility and depth compared to Olympus' conventional models, and is designed to display fine vascular structures with a clear NBI observation mode that minimizes noise. The improvement in color reproducibility and LED light source enhances the contrast and visibility of blood vessels and mucosa, contributing to more precise observations and detection of lesion areas.
2. Integrated video system and stroboscopic light source to improve operability and diagnostic accuracy.
This product has integrated a video system and a stroboscopic observation light source. This enables switching between white light observation and stroboscopic observation with the touch of a button, contributing to improved operability and diagnostic accuracy.
With support for HD camera heads, it enables precise inspections.
VISERA S is also compatible with Olympus' HD camera heads, enhancing equipment compatibility in medical institutions and contributing to achieving precise inspections for various patients and cases.
By improving the inspection record storage function, it supports efficient follow-up of patients.
While conventional Olympus models could only save still images, VISERA S allows for high-quality still image storage and video recording, enabling clearer records and supporting comprehensive report creation. This aims to streamline patient follow-up processes such as diagnosis and postoperative observations.
Olympus aims to achieve the health, safety, and enrichment of people around the world as our purpose. We, as a leading global medtech company, will contribute to improving the medical standards for the target disease by providing optimal solutions and services that assist in the early detection, diagnosis, and low-invasion treatment of the lesions, in collaboration with medical professionals. Since our founding over 100 years ago, we will continue to aim to contribute to society by providing products that bring optimal value to customers worldwide. For more information, please visit the Olympus official website () and X (@ Olympus_Corp_JP).
*The published content contains information as of the date of announcement, and the information may be changed (discontinued production and sales, changes in specifications, prices, etc.) without notice at the time of viewing.
*The published content is information released to the press, shareholders, investors, and others. It may include information on medical devices (including unapproved pharmaceuticals and medical devices), but the content is not intended for advertising or medical advice.
*We do not assume any responsibility for any damages arising from the use of the published content.
*The company and product names published in this release are trademarks or registered trademarks of their respective companies.
